Pro-Liance Services at a glance
We support you in bringing your medical devices and IVDs
to market quickly and efficiently.
Clinical evaluation (CER)
During the clinical evaluation, we collect, assess and analyze the relevant data relating to the clinical use of your medical device. This proves the safety and performance of your medical device and demonstrates that your product fulfills its intended purpose and the promised clinical benefits.
View Service
PMS / PMCF
We develop appropriate post-market surveillance strategies and carry out suitable activities to monitor the use of your medical device on the market. In this way, we can check the performance of your product on the market and ensure increased safety on the market by identifying unknown risks.
View Service
Risk Management
Carefully implemented risk management can significantly increase the safety of a medical device right from the development phase. Risks emanating from a product are systematically recorded and minimized through suitable measures.
View Service
Biological safety (BER)
As a manufacturer of medical devices, you are obliged to ensure the biological safety of your product in accordance with ISO standard 10993. Biological risks, such as the toxicity of materials used or production residues, must be minimized.
View Service
State of the Art
The assessment of the state of the art is essential for both established products and products under development. It identifies the risks and benefits of similar products and medical alternatives. A sound assessment of the state of the art is the basis for successful CE certification.
VIEW SERVICES
Performance evaluation (IVD)
The performance evaluation for in-vitro diagnostic devices includes clinical performance, analytical performance and scientific validity. This ensures that your IVD achieves the intended clinical benefit and meets the requirements of the IVDR.
View Service
Quality Management (QM)
As a manufacturer of medical devices, you must develop, implement and maintain a QM system in accordance with the MDR and IVDR. Depending on the risk class, a certified QM system in accordance with ISO 13485 and the requirements of the MDR or IVDR is mandatory.
VIEW SERVICES
SSCP
Since the introduction of the Medical Device Regulation (MDR) and the In Vitro Diagnostic Medical Device Regulation (IVDR) in 2017, manufacturers of medical devices and higher-risk in vitro diagnostic medical devices must prepare a Summary of Safety and Clinical Performance (SSCP) or Safety and Performance Summary (SSP). We support you in meeting these requirements.
View Service